Proposed Data Collection Submitted for Public Comment and Recommendations, 24799-24800 [2023-08569]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 78 / Monday, April 24, 2023 / Notices
record of this proceeding, including the
https://www.regulations.gov website.
Due to the public health emergency in
response to the COVID–19 outbreak and
the agency’s heightened security
screening, postal mail addressed to the
Commission will be subject to delay. We
encourage you to submit your comments
online through the https://
www.regulations.gov website.
If you prefer to file your comment on
paper, write ‘‘Paperwork Reduction Act
Comment: FTC File No. P072108’’ on
your comment and on the envelope, and
mail your comment to the following
address: Federal Trade Commission,
Office of the Secretary, 600
Pennsylvania Avenue NW, Suite CC–
5610 (Annex J), Washington, DC 20580;
or deliver your comment to the
following address: Federal Trade
Commission, Office of the Secretary,
Constitution Center, 400 7th Street SW,
5th Floor, Suite 5610 (Annex J),
Washington, DC 20024. If possible,
submit your paper comment to the
Commission by courier or overnight
service.
Because your comment will become
publicly available at https://
www.regulations.gov, you are solely
responsible for making sure that your
comment does not include any sensitive
or confidential information. In
particular, your comment should not
include any sensitive personal
information, such as your or anyone
else’s Social Security number; date of
birth; driver’s license number or other
state identification number, or foreign
country equivalent; passport number;
financial account number; or credit or
debit card number. You are also solely
responsible for making sure that your
comment does not include any sensitive
health information, such as medical
records or other individually
identifiable health information. In
addition, your comment should not
include any ‘‘trade secret or any
commercial or financial information
which . . . is privileged or
confidential’’—as provided by Section
6(f) of the FTC Act, 15 U.S.C. 46(f), and
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
VerDate Sep<11>2014
18:50 Apr 21, 2023
Jkt 259001
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov, we cannot redact
or remove your comment unless you
submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
The FTC Act and other laws that the
Commission administers permit the
collection of public comments to
consider and use in this proceeding, as
appropriate. The Commission will
consider all timely and responsive
public comments that it receives on or
before June 23, 2023. For information on
the Commission’s privacy policy,
including routine uses permitted by the
Privacy Act, see https://www.ftc.gov/
site-information/privacy-policy.
Josephine Liu,
Assistant General Counsel for Legal Counsel.
[FR Doc. 2023–08533 Filed 4–21–23; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–0740; Docket No. CDC–2023–
0026]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Medical
Monitoring Project (MMP). The purpose
of this data collection is to guide
national and local HIV-related service
organization and delivery, and monitor
receipt of HIV treatment and prevention
services and clinical outcomes.
SUMMARY:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
24799
CDC must receive written
comments on or before June 23, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0026 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
DATES:
E:\FR\FM\24APN1.SGM
24APN1
24800
Federal Register / Vol. 88, No. 78 / Monday, April 24, 2023 / Notices
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Medical Monitoring Project (MMP)
(OMB Control No. 0920–0740, Exp. 5/
31/2024)—Revision—National Center
for HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division of HIV
Prevention (DHP) requests a revision of
the currently approved Information
Collection Request: Medical Monitoring
Project (MMP) which expires 5/31/2024.
This data collection addresses the need
for national estimates of access to, and
utilization of HIV-related medical care
and services, the quality of HIV-related
ambulatory care, and HIV-related
behaviors and clinical outcomes. For the
project remain the same as in the
previously approved project. Changes
made, that did not affect the burden, are
listed below:
• Revisions to the interview
questionnaire were made to improve
coherence, boost the efficiency of the
data collection, and increase the
relevance and value of the information.
These changes did not affect the average
burden per response.
• Revisions to the medical record
abstraction data elements were made to
streamline the information collected
and add important questions related to
M-Pox vaccination. Because the medical
records are abstracted by MMP staff,
these changes do not affect the burden
of the project.
This proposed data collection would
supplement the National HIV
Surveillance System (NHSS, OMB
Control No. 0920–0573, Exp. 02/28/
2026) in 23 selected state and local
health departments, which collect
information on persons diagnosed with,
living with, and dying from HIV
infection and AIDS. The participation of
respondents is voluntary. There is no
cost to the respondents other than their
time. Total estimated annual burden
requested is 5,707 hours.
proposed project, the same data
collection methods will be used as for
the currently approved project. Data
would be collected from a probability
sample of HIV-diagnosed adults in the
U.S. who consent to an interview and
abstraction of their medical records. As
for the currently approved project,
deidentified information would also be
extracted from HIV case surveillance
records for a dataset (referred to as the
minimum dataset), which is used to
assess non-response bias, for quality
control, to improve the ability of MMP
to monitor ongoing care and treatment
of people with HIV, and to make
inferences from the MMP sample to
persons with diagnosed HIV nationally.
No other Federal agency collects such
nationally representative populationbased information from adults with
diagnosed HIV. The data are expected to
have significant implications for policy,
program development, and resource
allocation at the state/local and national
levels. The changes proposed in this
request update the data collection
system to meet prevailing information
needs and enhance the value of MMP
data, while remaining within the scope
of the currently approved project
purpose. The burden hours of the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Sampled, Eligible Persons with HIV
Facility office staff looking up contact
information.
Facility office staff approaching sampled persons for enrollment.
Facility office staff pulling medical
records.
Interview Questionnaire ...................
Look up contact information .............
7,760
1,940
1
1
45/60
2/60
5,173
65
Approach persons for Enrollment ....
970
1
5/60
81
Pull medical records .........................
7,760
1
3/60
388
Total ...........................................
...........................................................
........................
........................
........................
5,707
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–08569 Filed 4–21–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22IU]
Agency Forms Undergoing Paperwork
Reduction Act Review
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Evaluation of
Healthcare Worker Mental Health
Campaign’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
VerDate Sep<11>2014
18:50 Apr 21, 2023
Jkt 259001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on November
16, 2022 to obtain comments from the
public and affected agencies. CDC
received three comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 88, Number 78 (Monday, April 24, 2023)]
[Notices]
[Pages 24799-24800]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08569]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-0740; Docket No. CDC-2023-0026]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Medical Monitoring Project (MMP). The purpose of this data
collection is to guide national and local HIV-related service
organization and delivery, and monitor receipt of HIV treatment and
prevention services and clinical outcomes.
DATES: CDC must receive written comments on or before June 23, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0026 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
[[Page 24800]]
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Medical Monitoring Project (MMP) (OMB Control No. 0920-0740, Exp.
5/31/2024)--Revision--National Center for HIV, Viral Hepatitis, STD,
and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), Division of
HIV Prevention (DHP) requests a revision of the currently approved
Information Collection Request: Medical Monitoring Project (MMP) which
expires 5/31/2024. This data collection addresses the need for national
estimates of access to, and utilization of HIV-related medical care and
services, the quality of HIV-related ambulatory care, and HIV-related
behaviors and clinical outcomes. For the proposed project, the same
data collection methods will be used as for the currently approved
project. Data would be collected from a probability sample of HIV-
diagnosed adults in the U.S. who consent to an interview and
abstraction of their medical records. As for the currently approved
project, deidentified information would also be extracted from HIV case
surveillance records for a dataset (referred to as the minimum
dataset), which is used to assess non-response bias, for quality
control, to improve the ability of MMP to monitor ongoing care and
treatment of people with HIV, and to make inferences from the MMP
sample to persons with diagnosed HIV nationally. No other Federal
agency collects such nationally representative population-based
information from adults with diagnosed HIV. The data are expected to
have significant implications for policy, program development, and
resource allocation at the state/local and national levels. The changes
proposed in this request update the data collection system to meet
prevailing information needs and enhance the value of MMP data, while
remaining within the scope of the currently approved project purpose.
The burden hours of the project remain the same as in the previously
approved project. Changes made, that did not affect the burden, are
listed below:
Revisions to the interview questionnaire were made to
improve coherence, boost the efficiency of the data collection, and
increase the relevance and value of the information. These changes did
not affect the average burden per response.
Revisions to the medical record abstraction data elements
were made to streamline the information collected and add important
questions related to M-Pox vaccination. Because the medical records are
abstracted by MMP staff, these changes do not affect the burden of the
project.
This proposed data collection would supplement the National HIV
Surveillance System (NHSS, OMB Control No. 0920-0573, Exp. 02/28/2026)
in 23 selected state and local health departments, which collect
information on persons diagnosed with, living with, and dying from HIV
infection and AIDS. The participation of respondents is voluntary.
There is no cost to the respondents other than their time. Total
estimated annual burden requested is 5,707 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Sampled, Eligible Persons with Interview 7,760 1 45/60 5,173
HIV. Questionnaire.
Facility office staff looking Look up contact 1,940 1 2/60 65
up contact information. information.
Facility office staff Approach persons 970 1 5/60 81
approaching sampled persons for Enrollment.
for enrollment.
Facility office staff pulling Pull medical 7,760 1 3/60 388
medical records. records.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 5,707
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2023-08569 Filed 4-21-23; 8:45 am]
BILLING CODE 4163-18-P
